Interventional Agents Safety and Pharmacokinetic Services (IASPS)

The National Institutes of Health is forecasting a future contract opportunity for Interventional Agents Safety and Pharmacokinetic Services, aimed at securing specialized scientific support to evaluate the safety profiles and pharmacokinetic behavior of interventional agents. This engagement will likely involve preclinical and clinical studies to assess absorption, distribution, metabolism, and excretion of therapeutic compounds, alongside toxicology and biodistribution analyses, to support regulatory submissions and clinical development pathways. The work will be performed under the agency’s research and development mandate, with services tailored to meet the evolving needs of NIH-funded therapeutic programs. The solicitation is classified under NAICS code 541714, indicating it pertains to research and development in the physical, engineering, and life sciences. The program point of contact is Jeremy Starr, who can be reached at jeremy.starr@nih.gov, while Miranda Adams serves as the contracting officer and can be contacted at miranda.adams@nih.gov. Although the exact scope, duration, and budget have not been finalized, the forecast indicates a forthcoming competitive procurement process with no set-aside designation announced. Interested parties should monitor the designated UI link for formal notice of solicitation, which is expected to follow the posted forecast date of May 25, 2026.